Logo image of 1GILD.MI

GILEAD SCIENCES INC (1GILD.MI) Stock Fundamental Analysis

BIT:1GILD - Euronext Milan - US3755581036 - Common Stock - Currency: EUR

87.06  -6.4 (-6.85%)

Fundamental Rating

6

Overall 1GILD gets a fundamental rating of 6 out of 10. We evaluated 1GILD against 71 industry peers in the Biotechnology industry. While 1GILD belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. 1GILD may be a bit undervalued, certainly considering the very reasonable score on growth This makes 1GILD very considerable for value investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

1GILD had positive earnings in the past year.
In the past year 1GILD had a positive cash flow from operations.
Each year in the past 5 years 1GILD has been profitable.
Each year in the past 5 years 1GILD had a positive operating cash flow.
1GILD.MI Yearly Net Income VS EBIT VS OCF VS FCF1GILD.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

1.2 Ratios

The Return On Assets of 1GILD (0.81%) is better than 70.42% of its industry peers.
With a decent Return On Equity value of 2.48%, 1GILD is doing good in the industry, outperforming 74.65% of the companies in the same industry.
With an excellent Return On Invested Capital value of 17.45%, 1GILD belongs to the best of the industry, outperforming 92.96% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for 1GILD is in line with the industry average of 13.59%.
The last Return On Invested Capital (17.45%) for 1GILD is above the 3 year average (15.57%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.81%
ROE 2.48%
ROIC 17.45%
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)15.57%
ROIC(5y)13.08%
1GILD.MI Yearly ROA, ROE, ROIC1GILD.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

1GILD has a Profit Margin of 1.67%. This is in the better half of the industry: 1GILD outperforms 73.24% of its industry peers.
In the last couple of years the Profit Margin of 1GILD has declined.
Looking at the Operating Margin, with a value of 37.70%, 1GILD belongs to the top of the industry, outperforming 92.96% of the companies in the same industry.
In the last couple of years the Operating Margin of 1GILD has grown nicely.
Looking at the Gross Margin, with a value of 78.26%, 1GILD is in the better half of the industry, outperforming 76.06% of the companies in the same industry.
In the last couple of years the Gross Margin of 1GILD has remained more or less at the same level.
Industry RankSector Rank
OM 37.7%
PM (TTM) 1.67%
GM 78.26%
OM growth 3Y1.21%
OM growth 5Y13.65%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.23%
1GILD.MI Yearly Profit, Operating, Gross Margins1GILD.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 1GILD is creating value.
Compared to 1 year ago, 1GILD has about the same amount of shares outstanding.
1GILD has less shares outstanding than it did 5 years ago.
The debt/assets ratio for 1GILD is higher compared to a year ago.
1GILD.MI Yearly Shares Outstanding1GILD.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B
1GILD.MI Yearly Total Debt VS Total Assets1GILD.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

1GILD has an Altman-Z score of 3.38. This indicates that 1GILD is financially healthy and has little risk of bankruptcy at the moment.
1GILD has a Altman-Z score of 3.38. This is amongst the best in the industry. 1GILD outperforms 84.51% of its industry peers.
1GILD has a debt to FCF ratio of 2.59. This is a good value and a sign of high solvency as 1GILD would need 2.59 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 2.59, 1GILD belongs to the best of the industry, outperforming 91.55% of the companies in the same industry.
1GILD has a Debt/Equity ratio of 1.29. This is a high value indicating a heavy dependency on external financing.
1GILD has a Debt to Equity ratio of 1.29. This is comparable to the rest of the industry: 1GILD outperforms 40.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF 2.59
Altman-Z 3.38
ROIC/WACC1.83
WACC9.52%
1GILD.MI Yearly LT Debt VS Equity VS FCF1GILD.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

1GILD has a Current Ratio of 1.60. This is a normal value and indicates that 1GILD is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.60, 1GILD is in line with its industry, outperforming 42.25% of the companies in the same industry.
1GILD has a Quick Ratio of 1.45. This is a normal value and indicates that 1GILD is financially healthy and should not expect problems in meeting its short term obligations.
1GILD's Quick ratio of 1.45 is on the low side compared to the rest of the industry. 1GILD is outperformed by 60.56% of its industry peers.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 1.45
1GILD.MI Yearly Current Assets VS Current Liabilites1GILD.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

4

3. Growth

3.1 Past

1GILD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 77.93%, which is quite impressive.
The Earnings Per Share has been decreasing by -7.01% on average over the past years.
Looking at the last year, 1GILD shows a small growth in Revenue. The Revenue has grown by 6.04% in the last year.
The Revenue has been growing slightly by 5.08% on average over the past years.
EPS 1Y (TTM)77.93%
EPS 3Y-14.17%
EPS 5Y-7.01%
EPS Q2Q%237.12%
Revenue 1Y (TTM)6.04%
Revenue growth 3Y1.74%
Revenue growth 5Y5.08%
Sales Q2Q%-0.28%

3.2 Future

Based on estimates for the next years, 1GILD will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.07% on average per year.
1GILD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.46% yearly.
EPS Next Y75.86%
EPS Next 2Y36.32%
EPS Next 3Y25.4%
EPS Next 5Y17.07%
Revenue Next Year1.43%
Revenue Next 2Y2.68%
Revenue Next 3Y3.32%
Revenue Next 5Y3.46%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
1GILD.MI Yearly Revenue VS Estimates1GILD.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B
1GILD.MI Yearly EPS VS Estimates1GILD.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.78, 1GILD is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of 1GILD indicates a rather cheap valuation: 1GILD is cheaper than 88.73% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 23.99, 1GILD is valued a bit cheaper.
With a Price/Forward Earnings ratio of 11.55, the valuation of 1GILD can be described as very reasonable.
Based on the Price/Forward Earnings ratio, 1GILD is valued cheaply inside the industry as 92.96% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 20.35. 1GILD is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 12.78
Fwd PE 11.55
1GILD.MI Price Earnings VS Forward Price Earnings1GILD.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

1GILD's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. 1GILD is cheaper than 87.32% of the companies in the same industry.
91.55% of the companies in the same industry are more expensive than 1GILD, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.95
EV/EBITDA 10.28
1GILD.MI Per share data1GILD.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

1GILD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of 1GILD may justify a higher PE ratio.
A more expensive valuation may be justified as 1GILD's earnings are expected to grow with 25.40% in the coming years.
PEG (NY)0.17
PEG (5Y)N/A
EPS Next 2Y36.32%
EPS Next 3Y25.4%

5

5. Dividend

5.1 Amount

1GILD has a Yearly Dividend Yield of 3.06%.
1GILD's Dividend Yield is rather good when compared to the industry average which is at 9.28. 1GILD pays more dividend than 91.55% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.44, 1GILD pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.06%

5.2 History

The dividend of 1GILD has a limited annual growth rate of 4.45%.
Dividend Growth(5Y)4.45%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

1GILD pays out 816.25% of its income as dividend. This is not a sustainable payout ratio.
The dividend of 1GILD is growing, but earnings are growing more, so the dividend growth is sustainable.
DP816.25%
EPS Next 2Y36.32%
EPS Next 3Y25.4%
1GILD.MI Yearly Income VS Free CF VS Dividend1GILD.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B
1GILD.MI Dividend Payout.1GILD.MI Dividend Payout, showing the Payout Ratio.1GILD.MI Dividend Payout.PayoutRetained Earnings

GILEAD SCIENCES INC

BIT:1GILD (5/7/2025, 7:00:00 PM)

87.06

-6.4 (-6.85%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)04-24 2025-04-24/amc
Earnings (Next)08-06 2025-08-06/amc
Inst Owners89.69%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap108.39B
Analysts80
Price Target100.03 (14.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.06%
Yearly Dividend2.77
Dividend Growth(5Y)4.45%
DP816.25%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.42%
Min EPS beat(2)9.39%
Max EPS beat(2)27.44%
EPS beat(4)4
Avg EPS beat(4)18.34%
Min EPS beat(4)9.39%
Max EPS beat(4)27.44%
EPS beat(8)5
Avg EPS beat(8)9.1%
EPS beat(12)9
Avg EPS beat(12)10.84%
EPS beat(16)11
Avg EPS beat(16)7.78%
Revenue beat(2)2
Avg Revenue beat(2)4.74%
Min Revenue beat(2)3.87%
Max Revenue beat(2)5.61%
Revenue beat(4)4
Avg Revenue beat(4)3.59%
Min Revenue beat(4)1.47%
Max Revenue beat(4)5.61%
Revenue beat(8)6
Avg Revenue beat(8)1.62%
Revenue beat(12)10
Avg Revenue beat(12)3.55%
Revenue beat(16)13
Avg Revenue beat(16)3.68%
PT rev (1m)-3.99%
PT rev (3m)4.36%
EPS NQ rev (1m)0.09%
EPS NQ rev (3m)0.64%
EPS NY rev (1m)0.31%
EPS NY rev (3m)5.36%
Revenue NQ rev (1m)0.13%
Revenue NQ rev (3m)1.93%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)1.09%
Valuation
Industry RankSector Rank
PE 12.78
Fwd PE 11.55
P/S 4.28
P/FCF 11.95
P/OCF 11.37
P/B 6.37
P/tB N/A
EV/EBITDA 10.28
EPS(TTM)6.81
EY7.82%
EPS(NY)7.54
Fwd EY8.66%
FCF(TTM)7.29
FCFY8.37%
OCF(TTM)7.66
OCFY8.79%
SpS20.33
BVpS13.67
TBVpS-6.32
PEG (NY)0.17
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.81%
ROE 2.48%
ROCE 23.07%
ROIC 17.45%
ROICexc 22.16%
ROICexgc 93.82%
OM 37.7%
PM (TTM) 1.67%
GM 78.26%
FCFM 35.84%
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)15.57%
ROIC(5y)13.08%
ROICexc(3y)18.96%
ROICexc(5y)15.63%
ROICexgc(3y)99.97%
ROICexgc(5y)86.01%
ROCE(3y)20.58%
ROCE(5y)17.3%
ROICexcg growth 3Y0.13%
ROICexcg growth 5Y21.72%
ROICexc growth 3Y13.71%
ROICexc growth 5Y12.55%
OM growth 3Y1.21%
OM growth 5Y13.65%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.23%
F-Score7
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF 2.59
Debt/EBITDA 1.83
Cap/Depr 18.9%
Cap/Sales 1.82%
Interest Coverage 11.4
Cash Conversion 79.57%
Profit Quality 2146.88%
Current Ratio 1.6
Quick Ratio 1.45
Altman-Z 3.38
F-Score7
WACC9.52%
ROIC/WACC1.83
Cap/Depr(3y)25.08%
Cap/Depr(5y)29.48%
Cap/Sales(3y)2.21%
Cap/Sales(5y)2.28%
Profit Quality(3y)819.86%
Profit Quality(5y)1749.07%
High Growth Momentum
Growth
EPS 1Y (TTM)77.93%
EPS 3Y-14.17%
EPS 5Y-7.01%
EPS Q2Q%237.12%
EPS Next Y75.86%
EPS Next 2Y36.32%
EPS Next 3Y25.4%
EPS Next 5Y17.07%
Revenue 1Y (TTM)6.04%
Revenue growth 3Y1.74%
Revenue growth 5Y5.08%
Sales Q2Q%-0.28%
Revenue Next Year1.43%
Revenue Next 2Y2.68%
Revenue Next 3Y3.32%
Revenue Next 5Y3.46%
EBIT growth 1Y9.93%
EBIT growth 3Y2.97%
EBIT growth 5Y19.42%
EBIT Next Year78.52%
EBIT Next 3Y25.19%
EBIT Next 5Y17.4%
FCF growth 1Y38.86%
FCF growth 3Y-1.57%
FCF growth 5Y4.37%
OCF growth 1Y35.25%
OCF growth 3Y-1.66%
OCF growth 5Y3.44%